Newsletter | April 24, 2026

04.24.26 -- STREAM Edition: Biosimilars And Complex Medicines For All With RNA Therapeutics' Sarfaraz Niazi, Ph.D.

SPONSOR

 

 

Join Bioprocess Online’s Tyler Menichiello on April 28 at 11AM ET. for an interactive panel discussion examining how regulatory lag, evolving biocompatibility standards, and the complexity of converting legacy systems slow the uptake of innovative single-use materials in biomanufacturing. Register for free today.

Collaborating For A Sustainable Future

Video | Sartorius

Explore how cross-industry partnerships are driving sustainable process intensification to enable faster innovation, reduced waste, and long-term progress through shared goals and scalable solutions.

The ICH Q5A Revision, Its New Scope And Guidance

Video | MilliporeSigma

Learn about the ICH Q5A revision addressing viral safety of biotechnology products derived from cell lines of human or animal origin that was recently published for public comment.

Building Better BioTherapeutics Using Machine Learning

Webinar | ATUM

Understand more about high-throughput biologic automation and GMP master cell banking services, as well as variable selection services that search the SQL space to find promoters.

Biosimilars And Complex Medicines For All With RNA Therapeutics' Sarfaraz Niazi, Ph.D.

Video | Life Science Leader

On this week's episode of the Business of Biotech, we speak with Dr. Sarfaraz Niazi, Ph.D., about how biosimilar regulations have taken shape, from early FDA uncertainty to citizen petitions, lawsuits, and guideline changes.

Taking An Institutional Approach To PAT Implementation

Video | Bioprocess Online

In this segment from the Bioprocess Online Live event, our panelists emphasize the importance of strategic planning for PAT implementation and the value of cross-training. Mengyao Li, Ph.D., suggests taking a stage-gated approach.

EV Content Vs. Function: Using Analytical Tools To Reveal The Connection

Webinar | RoosterBio

See how downstream processing affects CD73 expression and function on MSC-EVs through orthogonal analytical methods that connect vesicle content to biological activity and therapeutic potential.

SPONSOR

 

Webinar: Meeting Pharma Where It Is Today: How to Activate Industrial AI Under GxP, Governance, and Security Constraints

Explore how Industrial AI can move from insight to action in regulated pharma environments. This webinar examines how governance, validation, and human oversight help AI operate safely, securely, and transparently within GxP systems. Learn what’s working today to enable auditable, compliant adoption without compromising control, trust, or operational confidence. Click here to learn more.
 

Connect With Bioprocess Online: